Why Pharma Could Be India's Next Multibagger Sector | Expert Explained

India's pharmaceutical sector could be entering a long-term growth phase with strong opportunities across multiple segments. The industry is benefiting from innovation, rising domestic demand, the China+1 manufacturing shift, and expansion in healthcare services. Sudip Bandyopadhyay, Market Expert, believes Indian pharma is at a stage similar to where the IT sector was nearly two decades ago, with the potential to create significant long-term wealth. He highlights branded drug makers, CDMO companies, domestic-focused pharma firms, and hospital chains as the key growth drivers, saying these segments could continue to outperform and remain attractive for long-term investors.